| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Interim CEO &General Counsel
1 company
Vogt Frederick G is an Interim CEO &General Counsel at IOVANCE BIOTHERAPEUTICS, INC.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | IOVA Iovance Biotherapeutics, Inc. | Interim CEO &General Counsel | Buy | 25,000 | $1.69 | $42,250.00 | +7.2% | +30.8% | - | |
| Nov 28, 2022 | IOVA Iovance Biotherapeutics, Inc. | Interim CEO &General Counsel | Buy | 1,000 | $5.98 | $5,980.00 | +100.0% | +20.5% | -6.4% | |
| Jun 1, 2022 | IOVA Iovance Biotherapeutics, Inc. | Interim CEO &General Counsel | Buy | 1,000 | $6.44 | $6,440.00 | New | +63.8% | +36.8% |